These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. 'Diagnostic orphans' among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria. Degenhardt L; Lynskey M; Coffey C; Patton G Drug Alcohol Depend; 2002 Jul; 67(2):205-12. PubMed ID: 12095670 [TBL] [Abstract][Full Text] [Related]
43. An exploration of multivariate symptom clusters of cannabis use disorder in young adults. Howe LK; Bailey AJ; Ingram PF; Finn PR Addict Behav; 2022 Dec; 135():107465. PubMed ID: 35995015 [TBL] [Abstract][Full Text] [Related]
44. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. Feingold D; Livne O; Rehm J; Lev-Ran S Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333 [TBL] [Abstract][Full Text] [Related]
45. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol. Compton WM; Dawson DA; Goldstein RB; Grant BF Drug Alcohol Depend; 2013 Sep; 132(1-2):387-90. PubMed ID: 23642316 [TBL] [Abstract][Full Text] [Related]
46. Validation of the Reasons for Quitting Smoking Cannabis Scale Among People with Cannabis Use Disorder. Stone BM; Gilbert DG Subst Use Misuse; 2024; 59(13):1950-1961. PubMed ID: 39252212 [TBL] [Abstract][Full Text] [Related]
47. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Budney AJ Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169 [TBL] [Abstract][Full Text] [Related]
48. Theoretical and observed subtypes of DSM-IV alcohol- and cannabis-use disorders in the Australian population. McBride O; Teesson M; Slade T; Baillie A J Stud Alcohol Drugs; 2010 Jul; 71(4):597-606. PubMed ID: 20553670 [TBL] [Abstract][Full Text] [Related]
49. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238 [TBL] [Abstract][Full Text] [Related]
50. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents. Mikulich SK; Hall SK; Whitmore EA; Crowley TJ Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688 [TBL] [Abstract][Full Text] [Related]
51. Cannabis withdrawal in patients with and without opioid dependence. Chauchard E; Goncharov O; Krupitsky E; Gorelick DA Subst Abus; 2014; 35(3):230-4. PubMed ID: 24745656 [TBL] [Abstract][Full Text] [Related]
52. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. Preuss UW; Watzke AB; Zimmermann J; Wong JW; Schmidt CO Drug Alcohol Depend; 2010 Jan; 106(2-3):133-41. PubMed ID: 19783382 [TBL] [Abstract][Full Text] [Related]
53. The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women. Werner KB; McCutcheon VV; Agrawal A; Sartor CE; Nelson EC; Heath AC; Bucholz KK Drug Alcohol Depend; 2016 May; 162():162-9. PubMed ID: 27012434 [TBL] [Abstract][Full Text] [Related]
54. Cannabis withdrawal in the United States: results from NESARC. Hasin DS; Keyes KM; Alderson D; Wang S; Aharonovich E; Grant BF J Clin Psychiatry; 2008 Sep; 69(9):1354-63. PubMed ID: 19012815 [TBL] [Abstract][Full Text] [Related]
55. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830 [TBL] [Abstract][Full Text] [Related]
56. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527 [TBL] [Abstract][Full Text] [Related]
57. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987 [TBL] [Abstract][Full Text] [Related]
58. Item response theory analysis of lifetime cannabis-use disorder symptom severity in an American Indian community sample. Gilder DA; Lau P; Ehlers CL J Stud Alcohol Drugs; 2009 Nov; 70(6):839-49. PubMed ID: 19895760 [TBL] [Abstract][Full Text] [Related]
59. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation. Richards DK; Schwebel FJ; Sotelo M; Pearson MR; Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399 [TBL] [Abstract][Full Text] [Related]
60. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Agrawal A; Neale MC; Prescott CA; Kendler KS Psychol Med; 2004 Oct; 34(7):1227-37. PubMed ID: 15697049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]